Another embargo break at PNAS, this time by author press release
The Proceedings of the National Academy of Sciences (PNAS) lifted the embargo early Monday on a paper after the company where some of its authors work broke it in a press release. Here’s a notice from the journal to the media on Monday, a few hours before the scheduled 3 p.m. Eastern lift:
PNAS is lifting the embargo early on the following paper. All other articles are under the scheduled embargo:
Article #15-06207: “Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology,” by Lihong Guo et al.
PNAS tells Embargo Watch:
We found a press release issued by the author on GlobeNewswire ahead of the scheduled embargo.
C3 Jian, Inc., a private company focused on re-engineering the human microbiome to deliver novel healthcare products, announced that its team of researchers, together with collaborators from UCLA, the University of Washington and the Craig Venter Institute have published a ground-breaking manuscript highlighting the targeted removal of bacteria and its impact on the remaining ecology of the microbiome.
C16G2 is being developed for the prevention of dental caries under an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) and is currently undergoing Phase 2 multi-center clinical trials.
The version of the release that broke the embargo, which was identical to the one in the link above, has been taken down.